These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22499962)

  • 1. Assessment of the standard pediatric unfractionated heparin dosing protocol.
    Al Obary EE; Al-Jazairi AS; Zaghloul IM; Saleh MM; Al Musa AS; Al-Halees Z
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):153-9. PubMed ID: 22499962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.
    Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P
    Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center.
    Balcezak TJ; Krumholz HM; Getnick GS; Vaccarino V; Lin ZQ; Cadman EC
    Am J Manag Care; 2000 Mar; 6(3):329-38. PubMed ID: 10977433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A standard heparin nomogram for the management of heparin therapy.
    Cruickshank MK; Levine MN; Hirsh J; Roberts R; Siguenza M
    Arch Intern Med; 1991 Feb; 151(2):333-7. PubMed ID: 1789820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation.
    Shalansky KF; FitzGerald JM; Sunderji R; Traboulay SJ; O'Malley B; McCarron BI; Naiman S
    Pharmacotherapy; 1996; 16(6):1076-84. PubMed ID: 8947981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of implementing the weight-based heparin nomogram as a practice guideline.
    Raschke RA; Gollihare B; Peirce JC
    Arch Intern Med; 1996 Aug 12-26; 156(15):1645-9. PubMed ID: 8694662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome.
    Joncas SX; Poirier P; Ardilouze JL; Carrier N; Fayad T; Farand P
    Obesity (Silver Spring); 2013 Sep; 21(9):1753-8. PubMed ID: 23404940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of unfractionated heparin using activated partial thromboplastin time: an assessment of the current nomogram and analysis according to age.
    Kim JS; Lee HJ; Sung JD; Kim HJ; Lee SY; Kim JS
    Clin Appl Thromb Hemost; 2014 Oct; 20(7):723-8. PubMed ID: 23615295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfractionated heparin therapy in infants and children.
    Newall F; Johnston L; Ignjatovic V; Monagle P
    Pediatrics; 2009 Mar; 123(3):e510-8. PubMed ID: 19221154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated partial thromboplastin time monitoring in patients receiving unfractionated heparin for venous thromboembolism in relation to clinical outcomes.
    Vardi M; Laor A; Bitterman H
    Thromb Haemost; 2009 Nov; 102(5):879-86. PubMed ID: 19888523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.
    Raschke RA; Reilly BM; Guidry JR; Fontana JR; Srinivas S
    Ann Intern Med; 1993 Nov; 119(9):874-81. PubMed ID: 8214998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two nomograms of unfractionated heparin in patients with acute coronary syndrome.
    Modares Mosadegh M; Sadr Bafghi SM
    Acta Med Iran; 2013 Mar; 51(2):87-93. PubMed ID: 23585314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
    Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.
    Kearon C
    Curr Opin Pulm Med; 2007 Sep; 13(5):398-402. PubMed ID: 17940484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of unfractionated heparin in critically ill patients.
    Aarab R; van Es J; de Pont AC; Vroom MB; Middeldorp S
    Neth J Med; 2013 Nov; 71(9):466-71. PubMed ID: 24218420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with heparin dosing at Christchurch Hospital.
    Ward ML; Duffull SB
    N Z Med J; 1998 Jun; 111(1068):228-30. PubMed ID: 9695751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction.
    Flaker GC; Bartolozzi J; Davis V; McCabe C; Cannon CP
    Arch Intern Med; 1994 Jul; 154(13):1492-6. PubMed ID: 8018004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.
    Kearon C; Harrison L; Crowther M; Ginsberg JS
    Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.